To contact the study team, select:
Continue as Guest - to notify the team of your request without creating a profile.
Register - will allow you to create a profile that you can later reference and view all the studies you have inquired about.
Login - If you have already Registered, select Login.
Enter Your Contact Information
Privacy Notice:
The data collected here will be used by UT Health San Antonio staff to contact you,
either by email or by telephone, with the sole purpose of providing you with information
regarding human study participation. You may be contacted in the future regarding studies
similar to this one. Under no circumstances will we use your information for other
purposes or share it with others. To the extent it is applicable,
UT Health San Antonio complies with the General Data Protection Regulation (“GDPR”).
Should you have any requests pertaining to your rights under the GDPR, please send it to:
The Office of Clinical Research ocrmail@uthscsa.edu | (210) 567-8555
Lay Description
This partially randomized phase II/III trial studies how well, in combination with surgery, cisplatin and combination chemotherapy works in treating children and young adults with hepatoblastoma or hepatocellular carcinoma. Drugs used in chemotherapy, such as cisplatin, doxorubicin, fluorouracil, vincristine sulfate, carboplatin, etoposide, irinotecan, sorafenib, gemcitabine and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving combination chemotherapy may kill more tumor cells than one type of chemotherapy alone.
To contact the study team, select:
Continue as Guest - to notify the team of your request without creating a profile.
Register - will allow you to create a profile that you can later reference and view all the studies you have inquired about.
Login - If you have already Registered, select Login.
Enter Your Contact Information
Privacy Notice:
The data collected here will be used by UT Health San Antonio staff to contact you,
either by email or by telephone, with the sole purpose of providing you with information
regarding human study participation. You may be contacted in the future regarding studies
similar to this one. Under no circumstances will we use your information for other
purposes or share it with others. To the extent it is applicable,
UT Health San Antonio complies with the General Data Protection Regulation (“GDPR”).
Should you have any requests pertaining to your rights under the GDPR, please send it to:
The Office of Clinical Research ocrmail@uthscsa.edu | (210) 567-8555
